About us

Products are registered in Russia and in 11 CIS countries

30 years on the market

We’re manufacturing drugs since 1991

Own manufacturing site

We based on essential chemical compounds

Unique quality control

In compliance with Russian and European standards

Easily accessible products

Non-prescription medicines

Own scientific base

Original drugs

Products are registered in Russia and in 11 CIS countries

  • More than 20 years on the market

    We’re manufacturing drugs since 1991

  • Own manufacturing site

    We based on essential chemical compounds

  • Easily accessible products

    Non-prescription medicines

  • Own scientific base

    Original drugs

  • Unique quality control

    In compliance with Russian and European standards

About us

Medical research and production complex

Biotiki — Effective. Innovative. Scientific

Director of "MNPK “BIOTIKI" Ya. R. Nartsissov, Ph.D, associate professor

For 30 years so far, the pharmaceutical company BIOTIKI has the honor of producing original medicines for you, which are based on essential chemical compounds (natural metabolites). Over the years, we have managed to achieve a verified and well-functioning system of production and quality control of our products that meets the highest European GMP standards.

The main strategic goal of our company is to create, maintain and develop a competitive manufacture in the pharmaceutical industry, corresponding to the world level of development of science and technology, as well as to ensure the availability of innovative medicines for the entire population of Russia.

More

Our awards

  • Award winner
    «Company of the year — 2015»

  • «Company №1 — 2016»
    «Reliable supplier of products and services»

Our history

Medical research and production complex "BIOTIKI" was founded in 1991 as an innovative pharmaceutical company with its original medicines. The company was founded by the team of the research laboratory of metabolism regulators under the leadership of Doctor of Medical Sciences, Professor Irina Alekseevna Komissarova.

A sharp reduction of state funding in the early 90s practically destroyed the prospects for the development of many branches of natural science and medicine. In this situation it was a bold and risky move to create the company focused on the development of new scientific ideas.